FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053266095> ?p ?o ?g. }

• W2053266095 endingPage "1253" @default.
• W2053266095 startingPage "1244" @default.
• W2053266095 abstract "An 18-month randomized double-blind study was conducted in postmenopausal women with osteoporosis to compare the effects of once-daily teriparatide 20 μg with alendronate 10 mg on bone histomorphometry. Biopsies were obtained from 42 patients. Indices of bone formation were significantly higher after 6 or 18 months of teriparatide compared with alendronate treatment. Introduction: Alendronate and teriparatide increased BMD, assessed by DXA, by different mechanisms of action, supported by changes in biochemical markers of bone turnover. The purpose of this cross-sectional study was to explore the differential effects of these two osteoporosis treatments at the bone tissue level by examining bone histomorphometric parameters of bone turnover after either 6 or 18 months of treatment. Materials and Methods: Patients were a cohort from a randomized parallel double-blind study conducted to compare the effects of once-daily teriparatide 20 μg and alendronate 10 mg in postmenopausal women with osteoporosis. Transiliac crest bone biopsies were obtained after tetracycline double labeling from 42 patients treated for 6 months (n = 23) or 18 months (n = 14); 5 additional patients were biopsied from contralateral sides at 6 and 18 months. Biopsy specimens adequate for quantitative analysis were analyzed by 2D histomorphometry from 17 patients at 6 months (teriparatide, n = 8; alendronate, n = 9) and 15 patients at 18 months (teriparatide, n = 8; alendronate, n = 7). Data were analyzed by two-sample tests. Results: Histomorphometric indices of bone formation were significantly and markedly greater in the teriparatide group than in the alendronate group at 6 and 18 months, whereas indices of bone resorption were only significantly greater in the teriparatide group than in the alendronate group at 6 months. Bone formation and activation frequency were significantly lower at 18 months compared with 6 months in the teriparatide group, returning to levels comparable with untreated postmenopausal women. In the teriparatide group, the peak in histomorphometric bone formation indices coincided with peak levels for N-terminal propeptide of type I collagen, a biochemical marker of bone formation. The degree of mineralization was lower at 18 months than at 6 months with treatment in both groups but was not different between groups. Conclusions: These results confirm the opposite mechanisms of action of teriparatide and alendronate on bone remodeling and confirm the bone formation effect of teriparatide." @default.
• W2053266095 created "2016-06-24" @default.
• W2053266095 creator A5014327442 @default.
• W2053266095 creator A5016118386 @default.
• W2053266095 creator A5039160459 @default.
• W2053266095 creator A5045265163 @default.
• W2053266095 creator A5054314099 @default.
• W2053266095 creator A5058758903 @default.
• W2053266095 creator A5059478181 @default.
• W2053266095 creator A5060560730 @default.
• W2053266095 creator A5067955208 @default.
• W2053266095 creator A5081801160 @default.
• W2053266095 creator A5082366563 @default.
• W2053266095 date "2005-03-14" @default.
• W2053266095 modified "2023-10-18" @default.
• W2053266095 title "Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters" @default.
• W2053266095 cites W1486762847 @default.
• W2053266095 cites W1532820515 @default.
• W2053266095 cites W1967976996 @default.
• W2053266095 cites W1977271471 @default.
• W2053266095 cites W1979462438 @default.
• W2053266095 cites W1989783674 @default.
• W2053266095 cites W2005298224 @default.
• W2053266095 cites W2007698435 @default.
• W2053266095 cites W2010486222 @default.
• W2053266095 cites W2011332812 @default.
• W2053266095 cites W2013599591 @default.
• W2053266095 cites W2015247179 @default.
• W2053266095 cites W2018503548 @default.
• W2053266095 cites W2019693617 @default.
• W2053266095 cites W2020571751 @default.
• W2053266095 cites W2023471859 @default.
• W2053266095 cites W2023781848 @default.
• W2053266095 cites W2026446264 @default.
• W2053266095 cites W2027905492 @default.
• W2053266095 cites W2032244293 @default.
• W2053266095 cites W2036690657 @default.
• W2053266095 cites W2041598849 @default.
• W2053266095 cites W2064081312 @default.
• W2053266095 cites W2072368452 @default.
• W2053266095 cites W2083011022 @default.
• W2053266095 cites W2087378917 @default.
• W2053266095 cites W2092654589 @default.
• W2053266095 cites W2094937528 @default.
• W2053266095 cites W2113162921 @default.
• W2053266095 cites W2118676056 @default.
• W2053266095 cites W2121098861 @default.
• W2053266095 cites W2127985847 @default.
• W2053266095 cites W2138900335 @default.
• W2053266095 cites W2143214738 @default.
• W2053266095 cites W2145733834 @default.
• W2053266095 cites W2149598802 @default.
• W2053266095 cites W2153009489 @default.
• W2053266095 cites W2154651971 @default.
• W2053266095 cites W2161546266 @default.
• W2053266095 cites W2161837912 @default.
• W2053266095 cites W2163477169 @default.
• W2053266095 cites W2170079690 @default.
• W2053266095 cites W2321227665 @default.
• W2053266095 cites W2335178464 @default.
• W2053266095 cites W35915495 @default.
• W2053266095 doi "https://doi.org/10.1359/jbmr.050309" @default.
• W2053266095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15940379" @default.
• W2053266095 hasPublicationYear "2005" @default.
• W2053266095 type Work @default.
• W2053266095 sameAs 2053266095 @default.
• W2053266095 citedByCount "203" @default.
• W2053266095 countsByYear W20532660952012 @default.
• W2053266095 countsByYear W20532660952013 @default.
• W2053266095 countsByYear W20532660952014 @default.
• W2053266095 countsByYear W20532660952015 @default.
• W2053266095 countsByYear W20532660952016 @default.
• W2053266095 countsByYear W20532660952017 @default.
• W2053266095 countsByYear W20532660952018 @default.
• W2053266095 countsByYear W20532660952019 @default.
• W2053266095 countsByYear W20532660952020 @default.
• W2053266095 countsByYear W20532660952021 @default.
• W2053266095 countsByYear W20532660952022 @default.
• W2053266095 countsByYear W20532660952023 @default.
• W2053266095 crossrefType "journal-article" @default.
• W2053266095 hasAuthorship W2053266095A5014327442 @default.
• W2053266095 hasAuthorship W2053266095A5016118386 @default.
• W2053266095 hasAuthorship W2053266095A5039160459 @default.
• W2053266095 hasAuthorship W2053266095A5045265163 @default.
• W2053266095 hasAuthorship W2053266095A5054314099 @default.
• W2053266095 hasAuthorship W2053266095A5058758903 @default.
• W2053266095 hasAuthorship W2053266095A5059478181 @default.
• W2053266095 hasAuthorship W2053266095A5060560730 @default.
• W2053266095 hasAuthorship W2053266095A5067955208 @default.
• W2053266095 hasAuthorship W2053266095A5081801160 @default.
• W2053266095 hasAuthorship W2053266095A5082366563 @default.
• W2053266095 hasBestOaLocation W20532660951 @default.
• W2053266095 hasConcept C126322002 @default.
• W2053266095 hasConcept C126894567 @default.
• W2053266095 hasConcept C141071460 @default.
• W2053266095 hasConcept C170033053 @default.
• W2053266095 hasConcept C199343813 @default.
• W2053266095 hasConcept C2776541429 @default.

• next